| Aug 12, 2025 |
Aug 14, 2025 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
46.3
|
-2,098
|
-17.04%
|
✗
|
$28.1K |
| May 1, 2025 |
May 7, 2025 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
46.3
|
-1,930
|
-22.81%
|
✗
|
$31.8K |
| Sep 20, 2024 |
Sep 24, 2024 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
17.5
|
-70,922
|
-91.60%
|
✗
|
$2M |
| May 1, 2024 |
May 3, 2024 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
46.3
|
-1,956
|
-37.56%
|
✗
|
$37K |
| Feb 7, 2024 |
Feb 9, 2024 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
7.5
|
-29,835
|
-100.00%
|
✓
|
$596.8K |
| Dec 27, 2023 |
Dec 28, 2023 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-8,497
|
-100.00%
|
✓
|
$89.2K |
| May 1, 2023 |
May 3, 2023 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
46.3
|
-1,897
|
-22.42%
|
✗
|
$16.9K |
| Oct 3, 2022 |
Oct 5, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
13.8
|
-4,730
|
-61.19%
|
✓
|
$46.2K |
| Sep 6, 2022 |
Sep 8, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-4,730
|
-61.19%
|
✓
|
$51.6K |
| Aug 3, 2022 |
Aug 5, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-9,232
|
-75.47%
|
✓
|
$85.9K |
| Jul 5, 2022 |
Jul 7, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-9,232
|
-60.61%
|
✓
|
$77.3K |
| Jun 16, 2022 |
Jun 21, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
7.5
|
-67,927
|
-88.30%
|
✓
|
$463.9K |
| Jun 13, 2022 |
Jun 15, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-26,381
|
-46.73%
|
✓
|
$160.5K |
| Jun 8, 2022 |
Jun 10, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-27,306
|
-75.21%
|
✓
|
$175.9K |
| Jun 3, 2022 |
Jun 7, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
7.5
|
-47,287
|
-79.76%
|
✓
|
$296K |
| May 16, 2022 |
May 18, 2022 |
Edgewise Therapeutics, Inc.
|
General Counsel |
Sell |
10.0
|
-10,800
|
-78.26%
|
✓
|
$80.1K |